In this article, the author examines how a proteomic atlas of the neointima identifies novel druggable targets for preventive therapy. It mentions migration of smooth muscle cells and fibroblasts from the outer layers towards the endoluminal face of the device eventually causes protrusion into the lumen, causing restenosis.